Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FYN | P06241 | 5/20 | 0.51 |
| ▸ | GRK5 | P34947 | 1/20 | 0.48 |
| ▸ | CSF1R | P07333 | 3/20 | 0.47 |
| ▸ | KIT | P10721 | 3/20 | 0.47 |
| ▸ | HCK | P08631 | 1/20 | 0.46 |
| ▸ | NR2C2 | P49116 | 1/20 | 0.46 |
| ▸ | BTK | Q06187 | 1/20 | 0.46 |
| ▸ | CAMK2D | Q13557 | 5/20 | 0.46 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.45 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.45 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | CCKAR | P32238 | 1/20 | 0.44 |
| ▸ | HTR5A | P47898 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759881 | 0.88 | EPHA2 (0.49) | FYNGRK5CSF1RKITHCK | |
| SCHEMBL6756711 | 0.87 | FYN (0.48) | FYNGRK5CSF1RKITHCK | |
| SCHEMBL6757951 | 0.84 | DYRK1A (0.46) | FYNMEN1MAPTKMT2A | |
| SCHEMBL6799452 | 0.84 | FYN (0.49) | FYNMAPT | |
| SCHEMBL7120246 | 0.82 | FYN (0.47) | FYNGRK5MEN1MAPTKMT2A | |
| SCHEMBL6804624 | 0.82 | DYRK1A (0.57) | FYNBTKMEN1MAPTKMT2A | |
| SCHEMBL27519956 | 0.78 | HCK (0.48) | CSF1RKITHCKNR2C2BTK | |
| SCHEMBL6759857 | 0.78 | ABL1 (0.56) | HCKNR2C2BTKEPHA2KCNK3 | |
| SCHEMBL6803237 | 0.77 | CSF1R (0.44) | CSF1RKITHCKNR2C2BTK | |
| SCHEMBL6808846 | 0.76 | MAPT (0.63) | MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040266774-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040266774-A1 | Amide compounds | TPH1, HTR1A, HTR5A | FYN 2025/4885GRK5 68/4885CSF1R 2490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.